Abstract:Hypercatabolism plays a critical role in the pathogenesis of post-critical care debility in critical patients. Central nervous system may exerte a critical role in the regulation of hypercatabolism. However, little is known about the exact mechanisms of the central role. Here, we reported that actived hypothalamic AMP-activated protein kinase (AMPK)-induced autophagy modulated the expression of POMC to ameliorate hypercatabolism in septic rats. Firstly, rats were i.c.v. injected with the lentiviral vector containing shRNA against POMC. Two weeks after injections, rats were intraperitoneally injected with LPS or saline. Twenty-four hours later, blood, skeletal muscle and hypothalamus tissues were obtained. Hypercatabolism markers and neuropeptides expression were detected. Then, rats were injected with AICAR or saline into third ventricle and promptly intraperitoneally injected with LPS or saline. Twenty-four hours after infection, blood, skeletal muscle and hypothalamus tissues were obtained. Hypercatabolism, hypothalamic AMPK-induced autophagy markers and neuropeptides expression were also detected. Results showed that sepsis would decrease the level of hypothalamic autophagy accompany with the alterations of POMC expression and hypercatabolism. Knocking out hypothalamus POMC expression could significantly ameliorate hypercatabolism. Moreover, Central activation of AMPK-induced autophagy pathway via third ventricle injection of AICAR, an AMPK activator, could efficiently ameliorate hypercatabolism as well as attenuate the elevated POMC expression rather than other neuropeptides. Taken together, these results suggested that hypothalamic AMPK-autophagy pathway as a regulatory pathway for POMC expression was essential for hypercatabolism during sepsis. And hypothalamic AMPK-autophagy activation could attenuate the POMC expression to ameliorate hypercatabolism. Pharmaceuticals with the ability of activating hypothalamic AMPK-autophagy pathway may be a therapeutic potential for hypercatabolism in septic patients.

Targeting AMP-activated protein kinase in sepsis

AMPK regulates immunometabolism in sepsis.

The Emerging Role of Adaptor Proteins in Regulating Innate Immunity of Sepsis

Role Of Ampk Alpha In Skeletal Muscle Glycometabolism Regulation And Adaptation In Relation To Sepsis

Research Advances of Cationic Antimicrobial Peptides in the Immune Response in Sepsis

Research progress on AMPK/mTOR signaling pathway involved in immunometabolic regulation in sepsis

The endotoxemia cardiac dysfunction is attenuated by AMPK/mTOR signaling pathway regulating autophagy.

Research progress on the roles and mechanisms underlying metabolic molecules involved in nutrition therapy and immune regulation in sepsis

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

Hypothalamic AMPK-induced Autophagy Ameliorates Hypercatabolism in Septic Rats by Regulating POMC Expression

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Molecular Pathways in Sepsis Pathogenesis: Recent Advances and Therapeutic Avenues

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

Progress of antimicrobial peptides in the treatment of sepsis

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules

Maackiain Protects Against Sepsis Via Activating AMPK/Nrf2/HO-1 Pathway

The pathogenesis and potential therapeutic targets in sepsis

Mitochondria-Derived Damage-Associated Molecular Patterns In Sepsis: From Bench To Bedside

Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications

Sepsis-induced AKI: From pathogenesis to therapeutic approaches